Prospective Study of C-Reactive Protein in Relation to the Development of Diabetes and Metabolic Syndrome in the Mexico City Diabetes Study
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Recent evidence suggests that C-reactive protein (CRP) may predict development of diabetes in Caucasian populations. We evaluated CRP as a possible risk factor of the development of diabetes and metabolic syndrome in a 6-year study of 515 men and 729 women from the Mexico City Diabetes Study. RESEARCH DESIGN AND METHODS—Baseline CRP, indexes of adiposity, and insulin resistance (homeostasis model assessment [HOMA-IR]) were used to predict development of the metabolic syndrome, defined as including two or more of the following: 1) dyslipidemia (triglyceride ≥2.26 mmol/l or HDL cholesterol ≤0.91 mmol/l in men and ≤1.17 mmol/l in women; <35 and 40 mg/dl for men and women); 2) hypertension (blood pressure >140/90 mmHg or on hypertensive medication); or 3) diabetes (1999 World Health Organization criteria). RESULTS—At baseline, CRP correlated significantly (P < 0.001) with all metabolic indexes in women, but less so in men. After 6 years, 14.2% of men and 16.0% of women developed the metabolic syndrome. Compared with tertile 1, women with CRP in the highest tertile had an increased relative risk of developing the metabolic syndrome by 4.0 (95% CI 2.0–7.9) and diabetes by 5.5 (2.2–13.5); these risks changed minimally after adjusting for BMI or HOMA-IR. The area under receiver-operating characteristic (ROC) curve for the prediction of the development of the syndrome was 0.684 for CRP, increasing to 0.706 when combined with BMI and to 0.710 for a complex model of CRP, BMI, and HOMA-IR. CONCLUSIONS—CRP was not a significant predictor of the development of the metabolic syndrome in men. Our data strongly support the notion that inflammation is important in the pathogenesis of diabetes and metabolic disorders in women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
Self-citationKoenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,964
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Cited by
The anti-inflammatory effect of exercise
Petersen, A. M. W., & Pedersen, B. K. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00164.2004 · Cited by 3,100
Inflammation: the link between insulin resistance, obesity and diabetes
Dandona, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.013 · Cited by 2,170
Esposito, K., Marfella, R., Ciotola, M., Di Palo, C., Giugliano, F., Giugliano, G., D'Armiento, M., D'Andrea, F., & Giugliano, D. (2004) · JAMA · doi:10.1001/jama.292.12.1440 · Cited by 2,126
Obesity and inflammation: the linking mechanism and the complications
Ellulu, M. S., Patimah, I., Khaza’ai, H., Rahmat, A., & Abed, Y. (2017) · Archives of Medical Science · doi:10.5114/aoms.2016.58928 · Cited by 1,982
Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes
Pickup, J. C. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.813 · Cited by 1,414
Low-Grade Systemic Inflammation and the Development of Type 2 Diabetes
Duncan, B. B., Schmidt, M. I., Pankow, J. S., Ballantyne, C. M., Couper, D., Vigo, A., Hoogeveen, R., Folsom, A. R., & Heiss, G. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1799 · Cited by 1,036
Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6
Park, H. S., Park, J. Y., & Yu, R. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.11.007 · Cited by 964
Orchard, T. J., Temprosa, M., Goldberg, R., Haffner, S., Ratner, R., Marcovina, S., Fowler, S., & for the Diabetes Prevention Program Research Group (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-8-200504190-00009 · Cited by 948
“For example, Han and colleagues (20) reported that C-reactive protein level predicted the metabolic syndrome in women but not men.”
BackgroundSelf-citationInsulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Fernández-Real, J. M., & Ricart, W. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0010 · Cited by 886
Inflammatory Markers and Risk of Type 2 Diabetes
Wang, X., Bao, W., Liu, J., OuYang, Y.-Y., Wang, D., Rong, S., Xiao, X., Shan, Z.-L., Zhang, Y., Yao, P., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0702 · Cited by 820
Inflammatory Markers and Risk of Developing Type 2 Diabetes in Women
Hu, F. B., Meigs, J. B., Li, T. Y., Rifai, N., & Manson, J. E. (2004) · Diabetes · doi:10.2337/diabetes.53.3.693 · Cited by 788
Minireview: Adiposity, Inflammation, and Atherogenesis
Lyon, C. J., Law, R. E., & Hsueh, W. A. (2003) · Endocrinology · doi:10.1210/en.2003-0285 · Cited by 761
Brain-derived neurotrophic factor (BDNF) and type 2 diabetes
Krabbe, K. S., Nielsen, A. R., Krogh-Madsen, R., Plomgaard, P., Rasmussen, P., Erikstrup, C., Fischer, C. P., Lindegaard, B., Petersen, A. M. W., Taudorf, S., et al. (2007) · Diabetologia · doi:10.1007/s00125-006-0537-4 · Cited by 703
Rutter, M. K., Meigs, J. B., Sullivan, L. M., D’Agostino, R. B., & Wilson, P. W. F. (2004) · Circulation · doi:10.1161/01.cir.0000136581.59584.0e · Cited by 664
The Metabolic Syndrome: Inflammation, Diabetes Mellitus, and Cardiovascular Disease
Haffner, S. M. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.11.010 · Cited by 560
Self-citationMartin, S. S., Qasim, A., & Reilly, M. P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.060 · Cited by 516
LaMonte, M. J., Barlow, C. E., Jurca, R., Kampert, J. B., Church, T. S., & Blair, S. N. (2005) · Circulation · doi:10.1161/circulationaha.104.503805 · Cited by 507
Obesity and Inflammation: Epidemiology, Risk Factors, and Markers of Inflammation
Rodríguez-Hernández, H., Simental-Mendía, L. E., Rodríguez-Ramírez, G., & Reyes-Romero, M. A. (2013) · International Journal of Endocrinology · doi:10.1155/2013/678159 · Cited by 481
Liu, C., Feng, X., Li, Q., Wang, Y., Li, Q., & Hua, M. (2016) · Cytokine · doi:10.1016/j.cyto.2016.06.028 · Cited by 470
“Some articles have been reported that differences between sexes in the diabetes risk associated with inflammatory markers [38,41].”
BackgroundGender differences in the metabolic syndrome and their role for cardiovascular disease
Regitz-Zagrosek, V., Lehmkuhl, E., & Weickert, M. O. (2006) · Clinical Research in Cardiology · doi:10.1007/s00392-006-0351-5 · Cited by 459
Costello, E. J., Foley, D. L., & Angold, A. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000184929.41423.c0 · Cited by 441
Gender Difference in the Impact of Type 2 Diabetes on Coronary Heart Disease Risk
Juutilainen, A., Kortelainen, S., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2898 · Cited by 431
Liver Markers and Development of the Metabolic Syndrome
Hanley, A. J. G., Williams, K., Festa, A., Wagenknecht, L. E., D’Agostino, R. B., & Haffner, S. M. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3140 · Cited by 419
Self-citationKip, K. E., Marroquin, O. C., Kelley, D. E., Johnson, B. D., Kelsey, S. F., Shaw, L. J., Rogers, W. J., & Reis, S. E. (2004) · Circulation · doi:10.1161/01.cir.0000115514.44135.a8 · Cited by 412
An immune origin of type 2 diabetes?
Kolb, H., & Mandrup-Poulsen, T. (2005) · Diabetologia · doi:10.1007/s00125-005-1764-9 · Cited by 394
“Atherosclerosis Risk in Communities Study (ARIC) [7, 8] 45–64 12,330 7 years 1,335 Factor VIII ↑ von Willenbrand factor ↑ Leucocyte count ↑ Orosomucoid ↑ Fibrinogen ↑ Sialic acid ↑ Serum albumin ↓ Women’s Health Study (WHS) [9] ≥45 27,628 4 years 188 CRP ↑ IL-6 ↑ Cardiovascular Health Study (CHS) [10] ≥65 5,888 3–4 ye…”
BackgroundInfluentialThe Metabolic Syndrome in South Asians: Epidemiology, Determinants, and Prevention
Misra, A., & Khurana, L. (2009) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0024 · Cited by 383
What Does Minor Elevation of C-Reactive Protein Signify?
Kushner, I., Rzewnicki, D., & Samols, D. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.06.057 · Cited by 372
Xu, A., Tso, A. W. K., Cheung, B. M. Y., Wang, Y., Wat, N. M. S., Fong, C. H. Y., Yeung, D. C. Y., Janus, E. D., Sham, P. C., & Lam, K. S. L. (2007) · Circulation · doi:10.1161/circulationaha.106.647503 · Cited by 360
Ridker, P. M., Pare, G., Parker, A., Zee, R. Y. L., Danik, J. S., Buring, J. E., Kwiatkowski, D., Cook, N. R., Miletich, J. P., & Chasman, D. I. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.03.015 · Cited by 343
Savoia, C., & Schiffrin, E. L. (2007) · Clinical Science · doi:10.1042/cs20060247 · Cited by 326
Inflammatory Process in Type 2 Diabetes: The Role of Cytokines
ALEXANDRAKI, K., PIPERI, C., KALOFOUTIS, C., SINGH, J., ALAVERAS, A., & KALOFOUTIS, A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1372.039 · Cited by 309
Lteif, A. A., Han, K., & Mather, K. J. (2005) · Circulation · doi:10.1161/circulationaha.104.520130 · Cited by 308
C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men
Laaksonen, D. E., Niskanen, L., Nyyss�nen, K., Punnonen, K., Tuomainen, T.-P., Valkonen, V.-P., Salonen, R., & Salonen, J. T. (2004) · Diabetologia · doi:10.1007/s00125-004-1472-x · Cited by 289
Satoh, N., Ogawa, Y., Usui, T., Tagami, T., Kono, S., Uesugi, H., Sugiyama, H., Sugawara, A., Yamada, K., Shimatsu, A., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2493 · Cited by 289
Di Napoli, M., Schwaninger, M., Cappelli, R., Ceccarelli, E., Di Gianfilippo, G., Donati, C., Emsley, H. C. A., Forconi, S., Hopkins, S. J., Masotti, L., et al. (2005) · Stroke · doi:10.1161/01.str.0000165929.78756.ed · Cited by 289
Endothelial inflammation in insulin resistance
SJOHOLM, A., & NYSTROM, T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)70804-7 · Cited by 278
Physiological Aging: Links Among Adipose Tissue Dysfunction, Diabetes, and Frailty
Stout, M. B., Justice, J. N., Nicklas, B. J., & Kirkland, J. L. (2017) · Physiology · doi:10.1152/physiol.00012.2016 · Cited by 272
“the risk of developing insulin resistance and diabetes (8, 49, 94, 95).”
BackgroundBurnout and Risk of Type 2 Diabetes: A Prospective Study of Apparently Healthy Employed Persons
Melamed, S., Shirom, A., Toker, S., & Shapira, I. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000242860.24009.f0 · Cited by 266
Genetic Variation, C-Reactive Protein Levels, and Incidence of Diabetes
Dehghan, A., Kardys, I., de Maat, M. P. M., Uitterlinden, A. G., Sijbrands, E. J. G., Bootsma, A. H., Stijnen, T., Hofman, A., Schram, M. T., & Witteman, J. C. M. (2007) · Diabetes · doi:10.2337/db06-0922 · Cited by 257
A major health hazard: The metabolic syndrome
Isomaa, B. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00646-5 · Cited by 245
The Metabolic Syndrome and Inflammation
Sutherland, J. P., McKinley, B., & Eckel, R. H. (2004) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2004.2.82 · Cited by 243
“1), which can affect insulin action, including leptin, adiponectin, TNF-(cid:2) , IL-6, CRP, and resistin.”
InfluentialDepressive symptoms and metabolic syndrome: is inflammation the underlying link?
Capuron, L., Su, S., Miller, A. H., Bremner, J. D., Goldberg, J., Vogt, G. J., Maisano, C., Jones, L., Murrah, N. V., & Vaccarino, V. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.019 · Cited by 219
“interleukin (IL)-6 and tumor-necrosis-factor (TNF)-alpha, represent risk factors for the development of this condition (7,8).”
BackgroundElevated Retinol-Binding Protein 4 Levels Are Associated with Metabolic Syndrome in Chinese People
Qi, Q., Yu, Z., Ye, X., Zhao, F., Huang, P., Hu, F. B., Franco, O. H., Wang, J., Li, H., Liu, Y., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1219 · Cited by 211
Dogru, T., Sonmez, A., Tasci, I., Bozoglu, E., Yilmaz, M. I., Genc, H., Erdem, G., Gok, M., Bingol, N., Kilic, S., et al. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.07.031 · Cited by 201
Prospective Association Between Lung Function and the Incidence of Diabetes
Ford, E. S., & Mannino, D. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2966 · Cited by 194
Low-dose endotoxemia and human neuropsychological functions
Krabbe, K. S., Reichenberg, A., Yirmiya, R., Smed, A., Pedersen, B. K., & Bruunsgaard, H. (2005) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.04.010 · Cited by 189
Caballero, A. E., Delgado, A., Aguilar-Salinas, C. A., Herrera, A. N., Castillo, J. L., Cabrera, T., Gomez-Perez, F. J., & Rull, J. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0019 · Cited by 151
Nesto, R. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01296.x · Cited by 140
C-reactive protein is linked to lower cognitive performance in overweight and obese women
Sweat, V., Starr, V., Bruehl, H., Arentoft, A., Tirsi, A., Javier, E., & Convit, A. (2008) · Inflammation · doi:10.1007/s10753-008-9065-3 · Cited by 72
Sen, Z. D., Danyeli, L. V., Woelfer, M., Lamers, F., Wagner, G., Sobanski, T., & Walter, M. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.12.020 · Cited by 65
The utility of fasting glucose for detection of prediabetes
Cheng, C., Kushner, H., & Falkner, B. E. (2006) · Metabolism · doi:10.1016/j.metabol.2005.10.003 · Cited by 55
“Both Creactive protein and proinsulin have been shown to predict development of diabetes in large cohort studies [20-24].”
Background
Metadata
- Authors
- Han, T. S., Sattar, N., Williams, K., Gonzalez-Villalpando, C., Lean, M. E. J., & Haffner, S. M.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2002-11-01
- Volume
- 25
- Issue
- 11
- Pages
- 2016-2021
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2101731399
- Cited by
- 513
- References
- 28
- FWCI
- 25.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.